U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Superinduction of CYP1A1 Gene Expression. Regulation of 2,3, 7,8-Tetrachlorodibenzo-P-Dioxin-Induced Degradation of Ah Receptor by Cycloheximide

Public Domain


Details

  • Personal Author:
  • Description:
    Cycloheximide superinduces the transcription of CYP1A1 in the presence of an agonist for the Ah receptor (AhR). To investigate the molecular target for "superinduction," we analyzed the agonist-induced degradation of AhR. Whereas 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD), a potent agonist of AhR, induces a rapid reduction of the AhR protein, cycloheximide blocks the down-regulation of steady state AhR. Analyses of the turnover of AhR reveal that cycloheximide blocks the shortening of the half-life of AhR by TCDD. Blocking of the TCDD-induced AhR degradation requires inhibition of protein synthesis, because (a) cycloheximide inhibits protein synthesis at the concentration at which it causes superinduction and inhibition of AhR degradation; and (b) puromycin, an inhibitor of protein synthesis by mimicking aminoacyl-tRNA, also blocks the TCDD-induced AhR degradation. The blocking of the TCDD-induced AhR degradation correlates with the superinduction of CYP1A1 gene expression in a time- and dose-dependent manner. Furthermore, cycloheximide is shown to increase the accumulation of the TCDD-activated AhR and the functional AhR x Arnt complex in nucleus. Collectively, our results reveal a mechanism of superinduction by cycloheximide by enhancing the stability of agonist-activated AhR. The finding that inhibition of protein synthesis blocks the TCDD-induced AhR turnover implicates a cycloheximide-sensitive, labile factor (designated as AhR degradation promoting factor, or ADPF) in controlling the removal of agonist-activated AhR in nucleus. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    0021-9258
  • Document Type:
  • Genre:
  • Place as Subject:
  • CIO:
  • Division:
  • Topic:
  • Location:
  • Volume:
    275
  • Issue:
    17
  • NIOSHTIC Number:
    nn:20020743
  • Citation:
    J Biol Chem 2000 Apr; 275(17):12676-12683
  • Contact Point Address:
    CDC/NIOSH/HELD/TMBB, Mailstop 3014, 1095 Willowdale Road, Morgantown, WV 26505
  • CAS Registry Number:
  • Federal Fiscal Year:
    2000
  • Peer Reviewed:
    True
  • Source Full Name:
    Journal of Biological Chemistry
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:424c3e79ed45c0cd4eefa39576bb4003041c6faa87fe451903c24752ea4fd46a6cd8f31424f6cbb58838aedae23ee2231b2249efc63d2db281b1b4b3f0f7be4f
  • Download URL:
  • File Type:
    Filetype[PDF - 391.74 KB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.